title: Is MDx cost-effective for infectious disease applications?
authors.forename: John
authors.initials: J
authors.lastname: Brunstein
mesh_terms: D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000175:diagnosis; D006801:Humans; D007239:Infections / Q000175:diagnosis*; D025202:Molecular Diagnostic Techniques / Q000191:economics*